| Basics |
Retractable Technologies, Inc
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. It offers 1mL tuberculin; allergy antigen VanishPoint syringes.
|
| IPO Date: |
May 4, 2001 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$24.55M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.48%
|
| Avg Daily Range (30 D): |
$0.02 | 2.66%
|
| Avg Daily Range (90 D): |
$0.02 | 2.88%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.1M |
| Avg Daily Volume (30 D): |
.04M |
| Avg Daily Volume (90 D): |
.09M |
| Trade Size |
| Avg Trade Size (Sh.): |
205 |
| Avg Trade Size (Sh.) (30 D): |
184 |
| Avg Trade Size (Sh.) (90 D): |
283 |
| Institutional Trades |
| Total Inst.Trades: |
35 |
| Avg Inst. Trade: |
$1.35M |
| Avg Inst. Trade (30 D): |
$3.19M |
| Avg Inst. Trade (90 D): |
$3.19M |
| Avg Inst. Trade Volume: |
.17M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.14M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
317K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.21
|
$.01
|
$
|
|
Diluted EPS
|
$-.21
|
$.01
|
$
|
|
Revenue
|
$ 37.9M
|
$ 10.09M
|
$ 10.45M
|
|
Gross Profit
|
$ -.92M
|
$ 1.69M
|
$ -.11M
|
|
Net Income / Loss
|
$ -6.45M
|
$ .37M
|
$ -.09M
|
|
Operating Income / Loss
|
$ -20.68M
|
$ -3.65M
|
$ -5.13M
|
|
Cost of Revenue
|
$ 38.82M
|
$ 8.4M
|
$ 10.55M
|
|
Net Cash Flow
|
$ -.47M
|
$ .4M
|
$ -.34M
|
|
PE Ratio
|
|
|
|
|
|
|
